The effect of lemborexant on insomnia in patients with psychiatric disorders: Detailed evaluation using the Athens Insomnia Scale
Abstract Aim Chronic insomnia disorder is common and associated with reduced quality of life. Benzodiazepine hypnotics are commonly prescribed for insomnia, but have potential side effects such as concentration impairment, somnolence, and dependence. Lemborexant (LEM) is an orexin receptor antagonis...
Main Authors: | Tomonori Murayama, Yuji Ito, Kenji Narita, Tetsuro Ishida, Shiro Hinotsu, Masahiko Fujita |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | PCN Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/pcn5.165 |
Similar Items
-
Safety and real-world efficacy of lemborexant in the treatment of comorbid insomnia
by: Narimasa Katsuta, et al.
Published: (2023-12-01) -
Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder
by: Valerie Arnold, et al.
Published: (2024-05-01) -
Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder
by: Amitabh Dash, et al.
Published: (2022-12-01) -
Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy
by: Maha Ahmad, et al.
Published: (2024-12-01) -
Treating insomnia with medications
by: J. F. Pagel, et al.
Published: (2018-06-01)